Hypothesis

Core idea: We hypothesize that age‑associated rise in circulating pro‑inflammatory cytokines triggers extracellular vesicle (EV) release from myeloid cells, which deliver specific microRNAs to resident stromal cells in brain, heart, cartilage and muscle, thereby re‑programming chondroitin sulfotransferase (CHST) activity without altering bulk transcript levels.

Mechanistic pathway

• Inflammatory cytokines (e.g., IL‑6, TNF‑α) increase with age → stimulate monocyte/macrophage EV shedding.
• EVs carry miR‑124, miR‑9, etc. that suppress CHST3/7 mRNA translation or promote CHST11/12/13 translation in target stromal cells.
• This post‑transcriptional shift changes C4S/C6S ratio locally, while bulk RNA‑seq of whole tissue shows no change.
• The altered sulfation makes ECM more inhibitory, contributing to reduced plasticity and stiffening.

Testable predictions

1. Aged mice will show elevated EVs containing specific miRNAs in serum; isolating these EVs and transferring them to young mice will recapitulate the increased C4S/C6S ratio in PNNs, cardiac valves, and cartilage within 2 weeks.
2. In vitro, treating primary astrocytes or fibroblasts with aged‑serum EVs will increase CHST11/12/13 protein activity (measured by sulfotransferase assay) without changing CHST mRNA levels.
3. Blocking EV release (e.g., with GW4869) or neutralizing the candidate miRNAs in aged animals will prevent the sulfation shift and improve neuroplasticity and cardiac compliance.
4. Circulating EV‑associated miRNA levels will correlate with individual C4S/C6S ratios measured in CSF‑derived proteoglycans and synovial fluid GAGs, predicting cognitive and motor decline.

Falsifiability If EV transfer does not alter sulfation patterns, or if miRNA manipulation fails to affect CHST protein activity, the hypothesis is falsified.

Relevance to cited work This model explains the compartmentalized regulation noted in [1] where bulk tissue assays miss PNN‑specific sulfotransferase changes, accounts for the coordinated GAG synthesis rise in cardiac tissue [2] and musculoskeletal aging [3], and provides a systemic link that could be accessed via serum EV biomarkers.